With Technology Developed at UM, Non-Profit MiRcore Provides miRNA Research Support | GenomeWeb

By Doug Macron

Aiming to fill a gap in the microRNA research field, non-profit startup MiRcore is on the lookout for collaborators interested in working with its proprietary miRNA target-prediction technology.

According to MiRcore Founder and President Inhan Lee, the organization is an outgrowth of her time as an investigator at the University of Michigan, where she saw “many people … [doing] microRNA research, but without any good support.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.